Targeting mitochondrial proteases for therapy of acute myeloid leukaemia

6Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Targeting cancer metabolism has emerged as an attractive approach to improve therapeutic regimens in acute myeloid leukaemia (AML). Mitochondrial proteases are closely related to cancer metabolism, but their biological functions have not been well characterized in AML. According to different categories, we comprehensively review the role of mitochondrial proteases in AML. This review highlights some ‘powerful’ mitochondrial protease targets, including their biological function, chemical modulators, and applicative prospect in AML.

Cite

CITATION STYLE

APA

Xiang, X., Bao, R., Wu, Y., & Luo, Y. (2022, July 1). Targeting mitochondrial proteases for therapy of acute myeloid leukaemia. British Journal of Pharmacology. John Wiley and Sons Inc. https://doi.org/10.1111/bph.15844

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free